Results 191 to 200 of about 206,338 (340)

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Sympathectomy in refractory ventricular arrhythmias in patients with left ventricular assist device: a grand round case report. [PDF]

Eur Heart J Case Rep
Fernández-Caso M, Carta-Bergaz A, Castrodeza J, Sousa-Casasnovas I, Ortiz-Bautista C, Pedraz-Prieto Á, Barrio-Gutiérrez JM, Bermejo J.   +7 more
europepmc   +1 more source

Long-Term In Vivo Left Ventricular Assist Device Study With a Titanium Centrifugal Pump

, 1998
Goro Ohtsuka, Kin‐ichi Nakata, Masaharu Yoshikawa, Juergen Mueller, Tamaki Takano, Shingo Yamane, Nicole Gronau, Julia Glueck, Yoshiyuki Takami, Akinori Sueoka, George V. Letsou, Heinrich Schima, Helmut Schmallegger, Ernst Wolner, Hitoshi Koyanagi, Akira Fujisawa, John C. Baldwin, Yukihiko Nosé   +17 more
openalex   +1 more source

High-intensity transient signals indicate a risk of cerebral embolism during left ventricular assist devices [PDF]

, 2000
Kazuhiko Hanzawa, Mitsuru Kitamura, Hajime Ohzeki, Hisanaga Moro, J Hayashi, Eisuke Furui, Hiroaki Naritomi   +6 more
openalex   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Prolonged ventricular fibrillation in a patient with left ventricular assist device

Türk Kardiyoloji Derneği Arşivi, 2018
Serkan Çay, Fırat Özcan, Özcan Özeke, Dursun Aras, Serkan Topaloğlu   +4 more
doaj   +1 more source

Driveline Relocation and Vacuum-Assisted Closure for Ventricular Assist Device Driveline Infections. [PDF]

J Cardiovasc Dev Dis
Saricaoglu MC, Kandemir M, Saricaoglu EM, Karacuha AF, Kadiroglu E, Abdullahi MF, Inan MB, Azap A, Akar AR.   +8 more
europepmc   +1 more source

Magnetic Suspension Controls for a New Continuous Flow Ventricular Assist Device

, 1997
E. Hilton, Paul E. Allaire, M. Baloh, Eric H. Maslen, G. Bearnson, Pratap S. Khanwilkar, Donald B. Olsen   +6 more
openalex   +1 more source

Chronic Unloading by Left Ventricular Assist Device Reverses Contractile Dysfunction and Alters Gene Expression in End-Stage Heart Failure [PDF]

, 2000
Paul M. Heerdt, Jeffrey W. Holmes, Bolin Cai, Alessandro Barbone, John D. Madigan, Steven Reiken, David L. Lee, Mehmet C. Öz, Andrew R. Marks, Daniel Burkhoff   +9 more
openalex   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source